Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFCAP.L Regulatory News (FCAP)

  • There is currently no data for FCAP

Option Grant

22 Aug 2023 08:00

RNS Number : 9833J
finnCap Group PLC
22 August 2023
 

22 August 2023

finnCap Group plc

("finnCap", "the Company" or the "Group")

Option Grant

finnCap today announces completion of the grant of options under the finnCap Group plc Company Share Option Plan (the "Plan") to John Farrugia, CEO. 

Due to various corporate transactions and closed periods, it has not previously been possible for the Company to complete the issue of these incentive awards to Mr Farrugia as intended upon his appointment as CEO on 1 September 2022 and as described in the Group's Remuneration Committee report included in the Company's Annual Report and Accounts for the year-ended 31 March 2022.

The grant comprises a retention option over 2,000,000 shares with an exercise price of 1p per share, and an incentive option over 5,000,000 shares with an exercise price of 15p per share (together the "Options"). Due to various corporate transactions and closed periods since his appointment as CEO it has not been possible to formalise the grant until now. In the ordinary course, the Options will vest and become exercisable on 25 July 2025, subject to continuing employment. For the avoidance of doubt, vesting will not accelerate on completion of the recommended all-share merger between finnCap and Cenkos Securities plc.

The Options are also subject to malus and clawback for a period of two years following vesting. The Options will lapse, to the extent not exercised, on the day immediately preceding the tenth anniversary of the date of grant.

Following these awards, John Farrugia continues to have a beneficial interest over 1,927,669 Ordinary Shares (as set out in the Company's Opening Position Disclosure dated 4 April 2023 under Rule 8 of the Takeover Code), representing approximately 1.06% of the current total voting rights of the Company, and has options over Ordinary Shares in the Company as set out below:

Name of Scheme or Plan

Number of ordinary shares under options/awards

Grant Date

Vesting date

Normal lapse date

Exercise price (per share)

finnCap Group plc Company Share Option Plan

305,045

05/12/2018

05/12/2020

05/12/2023

£0.28

152,523

05/12/2018

05/12/2021

05/12/2023

£0.28

152,522

05/12/2018

05/12/2022

05/12/2023

£0.28

425,000

01/04/2020

09/07/2024

09/07/2027

£0.175

666,667

18/08/2020

01/04/2022

01/04/2025

£0.01

666,667

18/08/2020

01/04/2023

01/04/2026

£0.01

2,000,000

22/08/2023

25/07/2025

22/08/2033

£0.01

5,000,000

22/08/2023

25/07/2025

22/08/2033

£0.15

finnCap Group plc Enterprise Management Share Option Plan

775,000

01/04/2020

09/07/20241

09/07/2027

£0.175

1 Subject to the satisfaction of performance conditions

The Company's Ordinary Shares referred to above are finnCap Group plc ordinary shares of 1 penny each and the total number of shares in issue is 181,094,844.

Further details on this are included in the notification below, made in accordance with the requirements of the UK Market Abuse Regulation.

Contacts

 

finnCap Group plc Tel: +44 (0) 20 7220 0500

Robert Lister, Chairman investor.relations@finncap.com

Richard Snow, Chief Financial Officer

 

Grant Thornton (Nominated Adviser)  Tel: +44 (0) 20 7383 5100

Philip Secrett/Samantha Harrison/Samuel Littler

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

John Farrugia

2

 

Reason for the notification

 

a)

 

Position/status

 

 

CEO

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

finnCap Group plc

b)

 

LEI

 

 

213800DLRUJW6JVNS533

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares

Identification code

GB00BGKPX309

b)

 

Nature of the transaction

 

 

(1) Grant of options over ordinary shares under the finnCap Group plc Company Share Option Plan at an exercise price of 1p per share

 

(2) Grant of options over ordinary shares under the finnCap Group plc Company Share Option plan at an exercise price of 15p per share

 

 

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

(1) £0.01

(1) 2,000,000

(2) £0.15

(2) 5,000,000

d)

 

Aggregated information

- Aggregated volume

N/A

- Price

e)

 

Date of the transaction

 

 

22 August 2023

f)

 

Place of the transaction

 

 

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAKPFAASDEFA
Date   Source Headline
28th Mar 201211:57 amRNSCompany update - Currency Exposure
21st Mar 20121:29 pmRNSNet Asset Value(s)
28th Feb 20129:23 amRNSCompany Update - Currency Exposure
24th Feb 201210:46 amRNSNet Asset Value(s)
21st Feb 20124:27 pmRNSNet Asset Value(s)
20th Feb 20124:19 pmRNSHalf Yearly Report
27th Jan 20123:55 pmRNSNet Asset Value(s)
27th Jan 20121:30 pmRNSCompany update - currency exposure
23rd Jan 201211:02 amRNS3rd compulsory partial redemption of shares
19th Jan 20121:05 pmRNSReplacement Net Asset Value(s)
18th Jan 20121:08 pmRNSNet Asset Value(s)
28th Dec 20112:33 pmRNSCompany Update - Currency Exposure
21st Dec 20113:31 pmRNSNet Asset Value(s)
20th Dec 20111:20 pmRNSNotice of compulsory partial redemption of shares
14th Dec 20113:21 pmRNSResult of AGM
28th Nov 20113:55 pmRNSCompany update - currency exposure
25th Nov 201110:57 amRNSNet Asset Value(s)
21st Nov 20114:29 pmRNSNet Asset Value(s)
17th Nov 20113:34 pmRNSNotice of AGM
4th Nov 20119:43 amRNSHoldings In Company
1st Nov 201111:03 amRNSAnnual Financial Report
31st Oct 201112:38 pmRNSAnnual Financial Report
28th Oct 201112:34 pmRNSNet Asset Value(s)
28th Oct 201111:11 amRNSHolding(s) in Company
28th Oct 201110:25 amRNSCompany Update - Currency Exposure
21st Oct 201111:36 amRNSNet Asset Value(s)
3rd Oct 20119:22 amRNSNet Asset Value(s)
28th Sep 20119:42 amRNSCompany update - currency exposure
21st Sep 20112:47 pmRNSNet Asset Value(s)
2nd Sep 201110:39 amRNSHolding(s) in Company
30th Aug 20114:41 pmRNSCompany Update - currency exposure
26th Aug 20115:03 pmRNSNet Asset Value(s)
19th Aug 20115:25 pmRNSNet Asset Value(s)
16th Aug 20114:18 pmRNSHolding(s) in Company
29th Jul 201110:33 amRNSNet Asset Value(s)
28th Jul 201112:20 pmRNSCompany update - Currency Exposure
21st Jul 20112:13 pmRNSUpdate-2nd compulsory partial redemption of shares
20th Jul 20115:50 pmRNSNet Asset Value(s)
14th Jul 20115:02 pmRNSNotice of compulsory partial redemption of shares
30th Jun 20112:17 pmRNSNet Asset Value(s)
28th Jun 20112:06 pmRNSCompany update - currency exposure
21st Jun 20114:23 pmRNSNet Asset Value(s)
27th May 20115:59 pmRNSNet Asset Value(s)
27th May 20112:06 pmRNSCompany update - currency exposure
24th May 201110:13 amRNSNet Asset Value(s)
11th May 201112:34 pmRNSUpdate - Notice of compulsory redemption of shares
4th May 201110:11 amRNSCompany update - currency exposure
3rd May 20114:01 pmRNSNotice of compulsory partial redemption of shares
28th Apr 20112:20 pmRNSNet Asset Value(s)
21st Apr 20113:33 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.